Notably, two monoclonal antibodies, aducanumab and lecanemab, have received traditional FDA approval for the treatment of AD [346,347,348]
Drug-induced dermatitis can look like eczema, hives, or red, scaly patches
86 : 135146 Fariello RG, Ferraro TN, Golden GT, DeMattei M

Semaglutide is prescribed for: Weight loss in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) Weight loss in adult patients with an initial body mass index (BMI) of 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (hypertension, type 2 diabetes mellitus, or dyslipidemia) Weight loss in pediatric patients aged 12 years and older with an initial BMI at the 95th percentile or greater for age and sex (obesity) Reducing the risk of major adverse cardiovascular events (non-fatal myocardial infarction, CV death, or non-fatal stroke) in adults with cardiovascular disease and either obesity or overweight Treating noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), formerly known as NASH, with moderate to advanced liver fibrosis (stages F2 to F3 fibrosis) in adults Patients taking semaglutide for any of these conditions, especially weight loss, are typically suggested to maintain a low-carb and low-fat diet

If you have diabetic retinopathy or other pre-existing eye conditions, our ophthalmologists may recommend exams every 3 to 6 months, especially during your first year on the medication